Jozi F, Kheiripour N, Taheri M, Ghavipanjeh G, Nasehi Z, Shahaboddin M
Iran J Basic Med Sci. 2024; 27(9):1162-1171.
PMID: 39055872
PMC: 11266743.
DOI: 10.22038/IJBMS.2024.74307.16141.
Iwasaki H
J Clin Transl Endocrinol. 2024; 36:100351.
PMID: 38799240
PMC: 11126532.
DOI: 10.1016/j.jcte.2024.100351.
Fu Z, Wang Z, Clemente K, Jaisinghani M, Poon K, Yeo A
Front Nephrol. 2024; 3:1237804.
PMID: 38260055
PMC: 10800693.
DOI: 10.3389/fneph.2023.1237804.
Gan C, Zhang Y, Zhang X, Huang Q, Guo X
Int J Gen Med. 2023; 16:5549-5558.
PMID: 38034901
PMC: 10683650.
DOI: 10.2147/IJGM.S440103.
Wahono A, Harnanik T, Pasaribu I, Adiwinoto R, Octavianda Y
BMC Endocr Disord. 2023; 23(1):254.
PMID: 37990213
PMC: 10664383.
DOI: 10.1186/s12902-023-01504-1.
Elevated serum trimethylamine oxide levels as potential biomarker for diabetic kidney disease.
Huang Y, Zhu Z, Huang Z, Zhou J
Endocr Connect. 2023; 12(8).
PMID: 37183928
PMC: 10388659.
DOI: 10.1530/EC-22-0542.
Process of Glucose Increases Rather Than Constant High Glucose Was the Main Cause of Abnormal Glucose Induced Glomerulus Epithelial Cells Inflammatory Response.
Qi J, Liu W, Gan L, Guo H, Xie Y, Gou L
Int J Mol Sci. 2023; 24(1).
PMID: 36614042
PMC: 9820529.
DOI: 10.3390/ijms24010600.
Metformin and growth differentiation factor 15 (GDF15) in type 2 diabetes mellitus: A hidden treasure.
Al-Kuraishy H, Al-Gareeb A, Alexiou A, Papadakis M, Nadwa E, Albogami S
J Diabetes. 2022; 14(12):806-814.
PMID: 36444166
PMC: 9789395.
DOI: 10.1111/1753-0407.13334.
Therapeutic potential for P2Y receptor antagonism.
Jasmer K, Munoz Forti K, Woods L, Cha S, Weisman G
Purinergic Signal. 2022; 19(2):401-420.
PMID: 36219327
PMC: 10247620.
DOI: 10.1007/s11302-022-09900-3.
Triglyceride-glucose index is prospectively associated with chronic kidney disease progression in Type 2 diabetes - mediation by pigment epithelium-derived factor.
Low S, Pek S, Moh A, Ang K, Khoo J, Shao Y
Diab Vasc Dis Res. 2022; 19(4):14791641221113784.
PMID: 35938490
PMC: 9364218.
DOI: 10.1177/14791641221113784.
The Role of the NLRP3 Inflammasome in Mediating Glomerular and Tubular Injury in Diabetic Nephropathy.
Williams B, Cliff C, Lee K, Squires P, Hills C
Front Physiol. 2022; 13:907504.
PMID: 35755447
PMC: 9218738.
DOI: 10.3389/fphys.2022.907504.
An Approach to Identify Therapeutic Target and Markers Associated with Diabetic Nephropathy.
Rai B, Maurya P, Srivastava M, Mishra P, Asif M, Tiwari S
Curr Diabetes Rev. 2022; 21(2):e100622205872.
PMID: 35702773
DOI: 10.2174/1573399819666220610191935.
Glomerular hyperfiltration.
Cortinovis M, Perico N, Ruggenenti P, Remuzzi A, Remuzzi G
Nat Rev Nephrol. 2022; 18(7):435-451.
PMID: 35365815
DOI: 10.1038/s41581-022-00559-y.
Potential of Polyphenols to Restore SIRT1 and NAD+ Metabolism in Renal Disease.
Tovar-Palacio C, Noriega L, Mercado A
Nutrients. 2022; 14(3).
PMID: 35277012
PMC: 8837945.
DOI: 10.3390/nu14030653.
Acylcarnitines: Can They Be Biomarkers of Diabetic Nephropathy?.
Mu X, Yang M, Ling P, Wu A, Zhou H, Jiang J
Diabetes Metab Syndr Obes. 2022; 15:247-256.
PMID: 35125878
PMC: 8811266.
DOI: 10.2147/DMSO.S350233.
Astragalus-Saffron-Rhubarb Mixture Delays the Progress of Diabetic Nephropathy in db/db Mice.
Zhou X, Liang Y, Qin L, Wei G, Wang J
Diabetes Metab Syndr Obes. 2021; 14:4679-4690.
PMID: 34916815
PMC: 8667760.
DOI: 10.2147/DMSO.S334662.
Comprehensive cost-effectiveness of diabetes management for the underserved in the United States: A systematic review.
Bosetti R, Tabatabai L, Naufal G, Menser T, Kash B
PLoS One. 2021; 16(11):e0260139.
PMID: 34793562
PMC: 8601459.
DOI: 10.1371/journal.pone.0260139.
Association of Urinary Sodium Excretion and Diabetic Kidney Disease in Patients With Type 2 Diabetes Mellitus: A Cross-Sectional Study.
Huang Y, Liu W, Liu J, Guo D, Zhang P, Liu D
Front Endocrinol (Lausanne). 2021; 12:772073.
PMID: 34777262
PMC: 8582599.
DOI: 10.3389/fendo.2021.772073.
Berberine Improves the Protective Effects of Metformin on Diabetic Nephropathy in db/db Mice through Trib1-dependent Inhibiting Inflammation.
Zhang B, Zhang X, Zhang C, Sun G, Sun X
Pharm Res. 2021; 38(11):1807-1820.
PMID: 34773184
DOI: 10.1007/s11095-021-03104-x.
Glomerular resistances predict long-term GFR decline in type 2 diabetic patients without overt nephropathy: a longitudinal subgroup analysis of the DEMAND trial.
Carrara F, Ruggenenti P, Perna A, Iliev I, Gaspari F, Ferrari S
Acta Diabetol. 2021; 59(3):309-317.
PMID: 34648087
DOI: 10.1007/s00592-021-01804-9.
